NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 262 filers reported holding NOVOCURE LTD in Q4 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $22,601,322 | +0.5% | 1,319,400 | -8.3% | 0.05% | -3.8% |
Q1 2024 | $22,490,007 | -7.8% | 1,438,900 | -12.0% | 0.05% | -8.8% |
Q4 2023 | $24,403,085 | +63.8% | 1,634,500 | +77.2% | 0.06% | +50.0% |
Q3 2023 | $14,896,760 | +408.4% | 922,400 | +1206.5% | 0.04% | +442.9% |
Q2 2023 | $2,929,900 | -13.2% | 70,600 | +25.8% | 0.01% | -22.2% |
Q1 2023 | $3,373,854 | -67.6% | 56,100 | -60.5% | 0.01% | -69.0% |
Q4 2022 | $10,408,365 | -24.6% | 141,900 | -21.9% | 0.03% | -27.5% |
Q3 2022 | $13,813,000 | -5.8% | 181,800 | -13.9% | 0.04% | -4.8% |
Q2 2022 | $14,671,000 | -34.0% | 211,100 | -21.3% | 0.04% | -28.8% |
Q1 2022 | $22,229,000 | -2.4% | 268,300 | -11.5% | 0.06% | +3.5% |
Q4 2021 | $22,764,000 | -40.0% | 303,200 | -7.2% | 0.06% | -41.8% |
Q3 2021 | $37,953,000 | -45.7% | 326,700 | +3.6% | 0.10% | -46.7% |
Q2 2021 | $69,940,000 | +17.1% | 315,300 | -30.2% | 0.18% | +12.2% |
Q1 2021 | $59,732,000 | -28.2% | 451,900 | -6.0% | 0.16% | -26.1% |
Q4 2020 | $83,215,000 | +14.4% | 480,900 | -26.4% | 0.22% | +6.7% |
Q3 2020 | $72,763,000 | +38.6% | 653,700 | -26.2% | 0.21% | +35.1% |
Q2 2020 | $52,510,000 | +25.1% | 885,500 | +42.0% | 0.15% | -4.3% |
Q1 2020 | $41,980,000 | -44.2% | 623,400 | -30.2% | 0.16% | -8.0% |
Q4 2019 | $75,278,000 | +12.5% | 893,300 | -0.1% | 0.18% | +6.7% |
Q3 2019 | $66,891,000 | +72.8% | 894,500 | +46.1% | 0.16% | +70.8% |
Q2 2019 | $38,716,000 | +51.3% | 612,300 | +15.2% | 0.10% | +47.7% |
Q1 2019 | $25,593,000 | +211.4% | 531,300 | +116.4% | 0.06% | +195.5% |
Q4 2018 | $8,219,000 | -56.8% | 245,500 | -32.3% | 0.02% | -52.2% |
Q3 2018 | $19,011,000 | +146.4% | 362,800 | +47.2% | 0.05% | +119.0% |
Q2 2018 | $7,715,000 | +1034.6% | 246,500 | +690.1% | 0.02% | +950.0% |
Q1 2018 | $680,000 | +222.3% | 31,200 | +198.6% | 0.00% | +100.0% |
Q4 2017 | $211,000 | – | 10,449 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |